Table 1.
Age 50–59 | ||||
Birth cohort | ||||
1942–1951 | 1953–1962 | Diff | P value of diff | |
Overall | ||||
Total | 9.67 (9.60 to 9.72) | 9.60 (9.53 to 9.68) | −0.07 | 0.128 |
Active | 5.90 (5.70 to 6.06) | 5.03 (4.73 to 5.32) | −0.87 | <0.001 |
Limited | 3.38 (3.24 to 3.57) | 3.92 (3.67 to 4.19) | 0.54 | <0.001 |
ADL disabled | 0.39 (0.32 to 0.45) | 0.66 (0.53 to 0.79) | 0.27 | <0.001 |
Men | ||||
Total | 9.64 (9.51 to 9.72) | 9.69 (9.56 to 9.80) | 0.05 | 0.210 |
Active | 6.46 (6.15 to 6.65) | 6.35 (5.88 to 6.70) | −0.11 | 0.616 |
Limited | 2.84 (2.66 to 3.10) | 2.85 (2.53 to 3.21) | 0.01 | 0.960 |
ADL disabled | 0.34 (0.25 to 0.43) | 0.49 (0.37 to 0.66) | 0.15 | 0.012 |
Women | ||||
Total | 9.70 (9.62 to 9.78) | 9.55 (9.46 to 9.65) | −0.15 | 0.026 |
Active | 5.43 (5.19 to 5.69) | 4.21 (3.92 to 4.56) | −1.22 | <0.001 |
Limited | 3.83 (3.63 to 4.07) | 4.58 (4.29 to 4.88) | 0.75 | <0.001 |
ADL disabled | 0.44 (0.35 to 0.51) | 0.76 (0.59 to 0.93) | 0.32 | <0.001 |
Age 60 – 69 | ||||
Birth cohort | ||||
1932–1941 | 1943–1952 | Diff | P value of diff | |
Overall | ||||
Total | 9.15 (9.02 to 9.26) | 9.13 (9.04 to 9.23) | −0.02 | 0.772 |
Active | 4.91 (4.72 to 5.12) | 3.78 (3.54 to 3.99) | −1.13 | <0.001 |
Limited | 3.67 (3.49 to 3.84) | 4.26 (4.07 to 4.46) | 0.59 | <0.001 |
ADL disabled | 0.57 (0.48 to 0.65) | 1.10 (0.97 to 1.23) | 0.53 | <0.001 |
Men | ||||
Total | 9.12 (8.94 to 9.29) | 9.05 (8.91 to 9.20) | −0.07 | 0.486 |
Active | 5.61 (5.32 to 5.89) | 4.79 (4.45 to 5.10) | −0.82 | <0.001 |
Limited | 3.12 (2.87 to 3.37) | 3.42 (3.20 to 3.68) | 0.30 | 0.002 |
ADL disabled | 0.40 (0.31 to 0.51) | 0.85 (0.70 to 0.97) | 0.45 | <0.001 |
Women | ||||
Total | 9.17 (9.03 to 9.33) | 9.19 (9.07 to 9.29) | 0.02 | 0.806 |
Active | 4.29 (4.04 to 4.58) | 2.95 (2.69 to 3.20) | −1.34 | <0.001 |
Limited | 4.17 (3.93 to 4.38) | 4.94 (4.67 to 5.17) | 0.77 | <0.001 |
ADL disabled | 0.71 (0.59 to 0.84) | 1.30 (1.16 to 1.49) | 0.59 | <0.001 |
Age 70 – 79 | ||||
Birth cohort | ||||
1922–1931 | 1933–1942 | Diff | P value of diff | |
Overall | ||||
Total | 8.43 (8.24 to 8.65) | 8.50 (8.35 to 8.62) | 0.07 | 0.578 |
Active | 3.66 (3.38 to 3.95) | 2.73 (2.45 to 2.90) | −0.93 | <0.001 |
Limited | 3.70 (3.47 to 3.95) | 4.13 (3.91 to 4.36) | 0.43 | <0.001 |
ADL disabled | 1.07 (0.91 to 1.22) | 1.64 (1.50 to 1.84) | 0.57 | <0.001 |
Men | ||||
Total | 8.39 (8.09 to 8.69) | 8.44 (8.22 to 8.62) | 0.05 | 0.782 |
Active | 4.40 (4.02 to 4.82) | 3.52 (3.16 to 3.77) | −0.88 | <0.001 |
Limited | 3.14 (2.83 to 3.46) | 3.67 (3.38 to 3.96) | 0.53 | <0.001 |
ADL disabled | 0.85 (0.68 to 1.02) | 1.25 (1.06 to 1.43) | 0.40 | <0.001 |
Women | ||||
Total | 8.48 (8.21 to 8.74) | 8.55 (8.37 to 8.70) | 0.07 | 0.650 |
Active | 2.95 (2.59 to 3.27) | 2.05 (1.74 to 2.23) | −0.90 | <0.001 |
Limited | 4.24 (3.92 to 4.65) | 4.53 (4.24 to 4.84) | 0.29 | 0.120 |
ADL disabled | 1.28 (1.04 to 1.54) | 1.98 (1.79 to 2.28) | 0.70 | <0.001 |
Data are life expectancy in years unless specified, with the 95% CI in brackets after point estimate. Models adjusted for age and sex (only for overall).
ADL, activities of daily living; Diff, difference.